NCS Healthcare recalls 1 mg Glycopyrrolate Tabs for potential impurities that could cause serious harm. This medication is for institutional use only and requires a prescription.
“NCS Healthcare Glycopyrrolate Tabs Recall: Impurities Risk Serious Harm.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37392-ncs-healthcare-glycopyrrolate-tabs-recall-impurities-risk-serious-harm. Based on FDA recall #D-0850-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0850-2020%22&limit=1).
NCS Healthcare of Kentucky Inc recalled Glycopyrrolate Tabs, USP, 1 mg, on Jan. 28, 2020, due to failed impurity specifications, according to the FDA. The Food and Drug Administration announced the Class II recall of 6,929 blister cards distributed nationwide.
The recall addresses high out-of-specification results for an individual unknown impurity in the drug product. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show NCS Healthcare of Kentucky Inc has one other recall on record since Oct. 27, 2023, involving Lisinopril Tablets and foreign Amlodipine tablets. Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (Dec. 15, 2025), Precision Dose Glycopyrrolate Oral Solution Recall (July 14, 2026), and Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026).
How to tell if you have this one
Check for the 30-count blister packs labeled 'Glycopyrrolate Tabs, USP, 1 mg' with NDC 0615-8170-39. This product was packaged by Vangard in Glasgow, KY and expires January 2020.
Brand
NCS Healthcare
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product label includes 'Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card' and NDC 0615-8170-39.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0850-2020 (January 28, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0850-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.